Houston, TX, June 02, 2022 (GLOBE NEWSWIRE) -- NuProbe Global, a genomics and molecular diagnostics company, announces the close of its $50M fundraising, co-led by AstraZeneca-CICC Fund, CR-CP Life Science...
Embrex, now a part of Zoetis (NYSE: ZTS), a global animal health company, developed and launched the world’s first commercial in ovo vaccination device more than 20 years ago. Its Inovoject® System is considered to be the industry standard for in ovo technology, revolutionized automation in the hatchery. Pfizer’s animal health division acquired Embrex in 2007.
Website
© 2022 Pappas Capital, LLC. ALL RIGHTS RESERVED.